Metabolomics in Endocrinology: The Way Forward

Area of Science:

• Metabolomics, a laboratory science focused on comprehensive analysis of low-molecular-weight molecules (<1 kDa).

Background:

• Metabolomics investigates cellular and metabolic defects underlying various disease processes.
• It involves high-throughput identification of endogenous and exogenous metabolites.

Purpose of the Study:

• To elucidate the role of metabolomics in understanding disease mechanisms.
• To explore its application in personalized treatment choices for precision medicine in endocrinology.

Main Methods:

• Utilizes mass spectrometry-based methods, including targeted and non-targeted approaches.
• The workflow encompasses sample acquisition, preparation, extraction, separation, ionization, data analysis, and metabolite identification.

Main Results:

• Identifies specific elevated metabolites associated with various endocrine conditions, such as diabetes (branched-chain amino acids), osteoporosis (carnitine, glutamate), pituitary tumors (deoxycholic acid, betahydroxybutyrate), and others.
• Demonstrates the potential of metabolomic profiling for disease-specific biomarker discovery.

Conclusions:

• Metabolomics offers valuable insights into metabolic alterations in disease.
• Its application can facilitate personalized treatment strategies within endocrinology.
• Technical complexity and cost-benefit considerations remain key challenges for widespread adoption.